Loading
Allied Corp. Stock: price and insider trades · United States
US·Mcap US$57.7k
No insider purchase over the last 90 days. The latest, by Robinson James George, was filed 27 Apr 2023.
Allied Corp.: what insiders have been doing
We have very little insider data for Allied Corp. so far: the most recent filing dates from 27 April 2023. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€16,396
1 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended August 2024 · cache
US$0.00
Analyst consensus
Income statement
RevenueUS$96.2k
Gross profit-US$323.1k-336% margin
EBITDA-US$3M-3106% margin
Net income-US$4M-4134.1% margin
Valuation
Beta-0.67
Balance sheet & cash
Market capUS$57.7k
Total debtUS$6.6M
Free Cash Flow-US$2M
Profitability & ownership
ROA-84.1%
% insiders0.0%
% institutions0.0%
Last declaration on 27 April 2023
Declarations1 total
40,000 shares@ US$0.45100.0% of flowCommon StockSEC:0001729637-23-000001:0
Canonical exit: 24 Jul 2023 (T+90)
1 of 1 declaration
About Allied Corp.
Allied Corp. is a company listed on the XNAS market, specializing in the health sector. It focuses on developing health and wellness-related products and services.
